ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prevalence, risk factors and prognostic value of anxiety and depression in recurrent glioma patients

Liu, Xiumei*; Zhan, Ge哈尔滨医科大学; 1
Psychology Health & Medicine2023-10-21DOI: 10.1080/13548506.2023.2221445
1被引18阅读
引用收藏
分享

摘要

Anxiety and depression are frequently noticed in glioma patients, while few studies report this issue in recurrent glioma patients. Hence, this study aimed to evaluate the prevalence of anxiety and depression, as well as their risk factors and prognostic value in recurrent glioma patients. Eighty recurrent glioma patients, 40 newly-diagnosed glioma patients, and 40 healthy controls were enrolled in this study. Then, the Hospital Anxiety and Depression Scale for anxiety (HADS-A) and for depression (HADS-D) were used to assess the anxiety and depression status of all subjects. The HADS-A score (8.6 +/- 3.3 vs. 7.0 +/- 2.9 vs. 4.3 +/- 2.5), anxiety rate (58.8% vs. 32.5% vs. 10.0%), HADS-D score (7.9 +/- 3.0 vs. 6.9 +/- 3.1 vs. 4.0 +/- 2.6), and depression rate (45.0% vs. 30.0% vs. 7.5%) were all highest in recurrent glioma patients, followed by newly-diagnosed glioma patients, and were lowest in healthy controls (all P < 0.001). Furthermore, female sex (vs. male sex) was independently correlated with anxiety (odds ratio (OR): 3.042, P = 0.029); meanwhile, higher World Health Organization (WHO) pathological grade was independently correlated with depression (OR: 2.573, P = 0.019) in recurrent glioma patients. Additionally, anxiety was correlated with shortened progression-free survival (PFS) (P = 0.028) and overall survival (OS) (P = 0.047), while depression only had a correlation trend with shortened PFS (without statistical significance) (P = 0.069) and was associated with shortened OS (P = 0.035) in recurrent glioma patients. The prevalence of anxiety and depression is high in recurrent glioma patients, which relates to gender, WHO pathological grade, and estimates worsen survival.

学科与关键词

关键词
Anxiety and depressionrecurrent gliomaprevalencerisk factorprognostic value
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Psychology Health & Medicine
发表日期
2023-10-21
卷期
第 28 卷, 第 9 期
页码
2474-2485
DOI
10.1080/13548506.2023.2221445
语言
ENGLISH
成果收录
SSCI · SCIE

作者

  • L

    Liu, Xiumei (通讯) (第一作者)

    1 · harbin med univ

  • Z

    Zhan, Ge

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417